Gross Profit: Revenues from operations less the associated costs.
EYEPOINT PHARMACEUTICALS, INC. (EYPT) had Gross Profit of $5.17M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$5.33M |
|
$-59.43M |
|
$0.17M |
|
|
Gross Profit |
$5.17M |
$67.56M |
|
$-62.23M |
|
$2.89M |
|
$-59.33M |
|
$-59.33M |
|
$-59.43M |
|
$-59.43M |
|
$-59.43M |
|
$-59.43M |
|
$-62.23M |
|
$-62.89M |
|
69.93M |
|
69.93M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$265.25M |
|
$8.76M |
|
$35.90M |
|
$301.15M |
|
$33.17M |
|
-- |
|
$21.96M |
|
$55.14M |
|
$246.01M |
|
$246.01M |
|
$246.01M |
|
68.89M |
|
| Cash Flow Statement Financials | |
$-115.71M |
|
$87.86M |
|
$-0.71M |
|
$99.85M |
|
$71.29M |
|
$-28.56M |
|
$14.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.91% |
|
-1166.83% |
|
-1166.83% |
|
-- |
|
-1112.56% |
|
-1114.31% |
|
$-117.20M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.06 |
|
8.53 |
|
10.55 |
|
-24.16% |
|
-24.16% |
|
-19.73% |
|
-24.16% |
|
$3.57 |
|
$-1.68 |
|
$-1.65 |
|